Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keytruda Approval Opens New Routes For Immuno-Oncology

May 25 2017

• By Mary Jo Laffler

PCR strip test tubes and micropipette in genetics laboratory. Toned photo

Related Content

Puma's Neratinib SUMMIT Study Shows Potential & Pitfalls Of Precision Medicine

Apr 03 2017

Biomarker-Led Claim Is Small Step For Merck's Keytruda, Giant Leap For Cancer Indications

May 23 2017

Roche Sees Biomarker-Guided Discovery As Key To Unlocking Tumor Microenvironment

Jun 18 2014

Roche's Post-Avastin Strategy Stumbles As Vanucizumab Fails In Phase II

Oct 21 2016

IDO Updates At ASCO: Incyte's Combos With Merck And Bristol Take Center Stage

May 19 2017

Roche's Oncology Strategy: The Long Game Comes Into Focus

Jun 15 2015

Milestones In Basket Trials: Novartis' Ambitious SIGNATURE Program

Sep 14 2015

Tissue-Agnostic Approach To Cancer Drug Development Takes A Hit

Sep 14 2015

Related Companies

Loxo Oncology at Lilly

Ignyta, Inc.

Novartis AG

Roche Holding AG

Puma Biotechnology, Inc.

Bristol Myers Squibb Company

Roche Holding AG

Additional Topics

Approvals Drug Approval Standards Regulation ImmunoOncology Cancer BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window